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and Surgery, Federico II University. Published byAbstract Background and aims: Diabetes is a suitable model to evaluate intervention pro-
grammes aimed at chronic diseases, because of its well-defined and measurable process and
outcome indicators. In this study, we aimed at investigating the effects of group based self-
management education on clinical and psychological variables in type 2 diabetes.
Methods and results: Four-year randomized controlled clinical trial (ISRCTN14558376) comparing
Group Care and traditional one-to-one care. Clinical and psychological variables were monitored
at baseline, 2 and 4 years. Although differences between groups appear to be non-significant at
univariate analysis, body weight, BMI and HbA1c, systolic and diastolic blood pressure improved
in the patients followed by Group Care but not among Controls. Prescription of lipid-lowering
and anti-hypertensive agents did not change among the patients on Group Care, whereas anti-
hypertensives were stepped up among Controls without improving their blood pressure. Multi-
variable analysis suggests that blood pressure improvement among patients on Group Care was
independent of BMI, duration of diabetes and antihypertensive medication, suggesting a direct
effect of education, presumably by increasing adherence. The “Powerful Others” dimension of
the Locus of Control worsened and fear of complications decreased among Controls.
Conclusions: The results confirm that a multidisciplinary structured group educational approach
improves blood pressure, presumably through better adherence to healthy lifestyle and medica-
tion, in people with type 2 diabetes.
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Chronic diseases represent a rising burden for the health of
ageing populations and for expenditure related to medi-
cation, complications, hospital admissions and rehabilita-
tion [1]. Hence, innovative strategies aimed at reducing
costs while improving health outcomes are sorely needed.
Diabetes is a suitable model to evaluate intervention
programmes aimed at chronic diseases, because of its
well-defined and measurable process and outcome in-
dicators [1]. The prevalence of type 2 diabetes (T2D), in
particular, is on the rise worldwide because of unhealthy
eating and sedentary lifestyles [2] while, on the other
hand, only half the patients achieve recommended thera-
peutic targets for metabolic and blood pressure control [3].
T2D requires on the part of those affected continuous
attention to lifestyle habits, adhesion to therapy, regular
follow up visits and ability to interact with health care
providers while not being overwhelmed by discourage-
ment from the moment they receive the diagnosis [4].
Consequently, an integrated approach to patient-centered
care will make sure that clinical decisions are taken with
an eye to possible barriers to adherence, such as individual
perception of illness, health literacy, cultural and religious
beliefs [5,6].
Patient education, especially self-management educa-
tion, is key to achieve the above goals. While traditional
education defines the problems, self-management educa-
tion allows patients to identify their problems and pro-
vides techniques to help them make decisions, take
appropriate action and alter actions as circumstances or
disease change [7,8]. Previous studies show how much the
educational approach, its conceptual framework and the
time dedicated to people are paramount in supporting
change in health behaviours [9], metabolic control [10]
and adherence to pharmacological treatment [11].
Within this context, we have validated a self-
management model that, with adequate pedagogic
approach, shifts the focus from the traditional organization
of diabetes care delivery to group training and education
activities that reallocate available resources in the clinic
while ameliorating patients' health indicators [12]. Our
Group Care model was reproducibly shown feasible and
effective in daily practise and transferable to other set-
tings, after adequate training of providers and engagement
of all stakeholders [12,13]. The aim of this study was to
investigate the effects on persons with T2D of participating
in group based self-management education compared to
individual education on clinical and psychological vari-
ables. On top of the effects on body weight, HbA1c and
blood pressure, we applied a battery of psychometric tools
to assess the Locus of Control, anxiety, depression and self-
esteem because, in previous reports, these were tested
only in post-hoc analyses [14,15] or a non-controlled
follow up of patients with type 1 diabetes managed by
Group Care [16].Methods
Study population
This was a parallel, randomized controlled clinical trial
(ISRCTN14558376) in which 50 people with T2D were
recruited through digital medical records of 90 patients in
our diabetes clinic and randomized to either Group Care
(n Z 25) or traditional one-to-one care (n Z 25) for a pre-
defined duration of 4 years (See CONSORT flow chart,
Supplementary Fig. 1). The patients were aged <80, had
at least 1-year previous attendance in our clinic and were
treated by lifestyle either alone or associated with non-
insulin anti-hyperglycaemic agents.
Our sample size had an 80% power to detect a differ-
ence of at least 12 mmHg decrease in systolic blood
pressure in the treated group (Group Care) with respect to
controls (standard care), with an alpha error <0.05. The
calculation was based upon the observed mean of the
control group at baseline (147 mmHg) and a common
standard deviation in the two groups of 15 mm/Hg.
Ethics approval
The study had been approved by the Institutional Ethics
Committees of Città della Salute e della Scienza di Torino
and Ordine Mauriziano di Torino. All patients signed their
informed consent to participate in the study, which con-
formed with the Declaration of Helsinki principles.
Patients
Recruitment began in June 2014, the trial started in
January 2015 and was regularly completed in December
2018. Data on gender, age, duration of diabetes, schooling,
living alone, occupation, smoking habits and anti-hyper-
glycaemic treatment are shown in Table 1 along with
clinical data at baseline.
Body weight and body mass index (BMI), fasting blood
glucose (glucose-oxidase), HbA1c (HPLC), systolic and
diastolic blood pressure, changes in anti-hyperglycaemic,
anti-hypertensive and lipid-lowering medication were
monitored 4-monthly. Yearly screening for complications
included serum creatinine, total and HDL cholesterol, tri-
glyceride, microalbuminuria/creatininuria ratio and
fundus examination. LDL Cholesterol was calculated ac-
cording to Friedewald's formula (total e HDL cholesterol e
triglyceride/5) [17]. eGFR was calculated according to the
Cockroft-Gault formula [18]. Psychological assessment was
done at baseline and after 2 and 4 years.
Blood pressure was measured by a physician (PF) after
5 min lying using a mercury sphygmomanometer. Fundus
examination was by digital retinal photography according
to Italian screening guidelines [19], following pupil dila-
tation by 1% tropicamide. Colour photographs of two 45
fields (centred on macula and nasal to disc) were graded
Table 1 Socio-demographical variables.
Group care (n Z 25) Controls (n Z 25) Significancea
Sex M Z 16; F Z 9 M Z 16; F Z 9 1.000
Age 62.1  9.1 62.6  7.5 0.883̂
Schoolingb 3/13/6/3 7/9/6/3 0.526
Occupation (Retired/Active in work) 15/10 15/10 1.000
Social status (Living alone/Married) 5/20 5/20 1.000
Known duration of diabetes (years) 12.9  5.2 9.6  4.2 0.016
Attendance in clinic before study (years) 9.3  4.1 7.0  3.3 0.008̂
Family history of DM (No/Yes) 9/16 7/18 0.544
Smoking (Never/Currently/Stopped) 8/1/16 9/9/7 0.007
Anti-hyperglycaemic treatment:
lifestyle only/anti-hyperglycaemic agents (AHA)
1/24 1/24 1.000
Bold means statistically significant.
a Chi-square test for categorical variables and t-test for continuous variables, or Ŵilcoxon rank-sum test.
b P Z Primary school. M Z Middle school. H Z High school. U Z University degree.
Education improves blood pressure in type 2 diabetes 1975by an expert physician (MP) and DR classified as: absent
(corresponding to ETDRS grade 10), mild (microaneurysms
only or isolated blot haemorrhages) (ETDRS grade 20),
moderate (ETDRS grade 35), severe non-proliferative
(ETDRS grades 47e53), or proliferative (ETDRS grades
>53) [20].
Anti-hyperglycaemic treatment was ranked both as
class of medication (lifestyle alone, anti-hyperglycaemic
agents) and number of agents prescribed (metformin,
sulphonylureas, GLP-1 receptor agonists, DPP4 inhibitors,
pioglitazone, SGLT2 inhibitors). Insulin, if introduced dur-
ing the study, was accounted for as overall dosage.
Changing from diet alone to anti-hyperglycaemic agents,
adding insulin to the latter and/or switching to insulin
alone ranked as one step up in medication.
Blood pressure medication was quantified as number of
different classes of anti-hypertensive drugs prescribed,
and lipid-active medication as prescription of statins and/
or ezetimibe and/or fenofibrate, according to clinical
judgement.Randomization
The Statistical Unit of the Dept. of Public Health and Pe-
diatrics carried out the subjects' allocation to either group.
Allocation was based on a 0 (Control group)/1 (Group Care)
sequence, with the first assignment randomly attributed to
one of the two groups. The three sub-unities of the Group
Care were composed on the basis of a randomly generated
sequence of numbers (from 1 to 25) after assigning each
subject a sequential number (from 1 to 25), based on the
alphabetical order of their surnames. After composing
three groups of 8 subjects, the 25th subject was randomly
assigned to one of the three groups.Group Care procedures
Twenty-five patients were randomized to Group Care and
assigned to 3 groups of 8e9 patients each, reorganizing
their booking schedules, while 25 controls continued with
traditional individual consultations. All patients werefollowed in the diabetes clinic by the same physician (PF)
for all aspects related to their clinical management.
The Group Care model to manage T2D was described
previously [15,21]. The intervention involves a series of 7
sessions or modules held every 3e4 months and repeated
twice over 4 years. Each module includes 3 phases: a)
welcome, b) the main content or topic of the session,
including role-playing with real life simulations, allowing
patients to express their opinions and tell their life expe-
rience with diabetes, and c) a final phase of summing up
and delivery of next appointment. Sessions last 60 min and
are followed by individual consultations with the physi-
cian to comment on clinical results and selected aspects of
the previous group session, address emerging problems, if
any, and yearly visits to screen for complications.
Psychometric evaluation
Four questionnaires were administered at baseline and
after 2 and 4 years to measure:
 anxiety and depression by the Hospital Anxiety e
Depression Scale (HADS) [22], consisting of 14 items
with two sub-scales. Scores of 11 or higher on either or
both sub-scales indicate moderate-severe symptoms or
a clinically significant disorder. Scores of 8e10 on either
sub-scale indicate mild levels of anxiety or depression;
 diabetes-specific Locus of Control by the Peyrot and
Rubin tool [23], including a set of 18 statements
measuring expectancies of Internal, Chance, and
“Powerful Others” control over diabetes-related health
outcomes. The questionnaire consists of 6 items for
each of 3 domains, measuring the degree to which
subjects consider their diabetes to be under their own
control, dependent on chance, or others. All items had
identical response options (from “strongly disagree”,
scoring 1, to “strongly agree”, scoring 6 on a 6-point
Likert-like format) and none required reverse scoring;
 quality of life, using a DQOL/Mod version translated and
revalidated into Italian [15,21] that includes 39 items.
Answers are along a 5-point Likert scale, from 1 (very
satisfied) to 5 (very dissatisfied). The Satisfaction
1976 M. Trento et al.section includes 14 items and explores the patients'
psychological well-being. The Impact dimension, 20
items, mostly assesses the practical consequences of
diabetes on everyday life. Finally, the 5-item “Worry:
Social-Vocational” Section investigates diabetes-related
anxiety, with special reference to clinical conditions.
The score ranges from 39 (best quality of life) to 195
(worst quality of life);
 self-esteem by the Rosenberg Self-Esteem Scale [24],
widely used in social-science research, that includes 10
items to be answered on a four-point Likert scale, from
“strongly agree” to “strongly disagree”. The scales
measure self-esteem by asking the respondents to
reflect on their current feelings. The score ranges from
10 to 40, where higher scores correspond to better
levels of self-esteem.
Statistical analysis
Analysis was by intention to treat. Data are shown as ab-
solute frequencies for categorical data and mean  SD for
continuous variables.
Chi-square test for categorical variables and t-test for
continuous variables, or Wilcoxon rank-sum test in case of
nonparametric distribution, were carried out to assess
whether significant differences between Group Care and
Controls could be shown for socio-demographic data at
baseline.
A t-test was then performed to compare the two groups
with respect to the mean differences between 4 years and
baseline for the clinical data taken into account in our
study.
Differences between values at baseline and after 2 and
4 years for clinical data and for the scores of psychometric
evaluation (anxiety and depression, locus of control,
quality of life, self-esteem) were checked in both groups by
paired t-test for continuous variables and Mc Nemar test
for categorical variables, as appropriate.
Finally, differences between Group Care and controls at
final evaluation were assessed by fitting multivariable
models where, for both HbA1c and systolic blood pressure
(SBP), the difference between final and baseline values
were the dependent variables and treatment group (Group
Care vs control group), known duration of diabetes, BMI
differences (4 years-baseline), baseline value of the
dependent variable and oral anti-hypertensive therapy at 4
years (for SBP model only) were taken as independent
variables.
For all tests, a p-value of less than 5% was considered
significant.
All analyses were performed with Stata 14 (StataCorp
LLC, Texas, USA).
Results
The patients were mostly retired, only a minority lived
alone and had a university degree. Despite randomization,
those followed by Group Care had longer disease duration
and attendance in clinic before study, and smoked less(Table 1). One of the patients randomized to Group Care
died during the study but there were no other dropouts
(Supplementary Fig. 1). In total, patients on Group Care
attended 14 sessions over 4 years and controls were seen
individually at regular intervals for the same total number
of visits.
Univariate analysis showed no significant differences for
nearly all clinical variables,when comparing the twogroups
for changes between 4 years and baseline (Tables 2 and 3),
the only exceptions being fasting blood glucose and the
Satisfaction dimension of the DQOL/Mod questionnaire.
On the other hand, within group analyses (Table 2)
showed that, by year 4, patients followed by Group Care
improved their body weight, BMI, HbA1c, systolic and
diastolic blood pressure. BMI and HbA1c had improved
already after the first 2 years (data not shown). There were
trends to reduction in total and HDL cholesterol and tri-
glyceride. None of the above changed significantly among
the patients followed by traditional visits, except for
transiently lower body weight, SBP and triglyceride levels
at 2 years (data not shown), not sustained at the end of
study. Serum creatinine increased, and eGRF declined, in
both groups. The level of diabetic retinopathy did not
change. Four patients in each group started insulin during
the study. Lipid-lowering and anti-hypertensive agents did
not change among the patients on Group Care, whereas
antihypertensive therapy was stepped up among Controls
(23 on medication at year 4 vs 17 at baseline, p Z 0.014),
without improving their blood pressure.
As regards psychological dimensions (Table 3) the
Satisfaction dimension of the DQOL/Mod improved among
the Controls. Within groups, at year 4, the “Powerful
Others” dimension of the Locus of Control increased, and
fear of complications decreased, among Controls. Non-
consistent changes occurred among the patients followed
by Group Care.
Multivariable analysis (Table 4) shows that, among the
patients followed by Group Care, blood pressure had
improved significantly, independently of BMI, known
duration of diabetes and antihypertensive medication,
suggesting a direct effect of Group Care. In contrast, the
improvement of HbA1c in Group Care patients was not
significantly different from controls after adjusting for
known duration of diabetes and BMI variation. Also the
Satisfaction dimension of the DQOL/Mod questionnaire did
not show a statistically significant difference between the
two groups after controlling for known duration of the
disease (data not shown).
Discussion
This paper confirms previous reports that self-
management education by Group Care has better effects
than standard care on people with T2D [12,13], presumably
by improving lifestyle as strongly suggested by the sus-
tained 4-year drop in body weight and HbA1c. A novel
observation in this trial is the drop in blood pressure,
which we did not observe previously and, according to
multivariable analysis, may have resulted not only from
Table 2 Clinical Variables at baseline and year 4 and comparisons between study groups.











Body weight (kg) 83.48  11.60 79.46  13.44 0.0044 77.50  10.97 75.72  11.41 0.0561 0.219
Body Mass Index (kg/m2) 29.62  3.38 28.05  3.41 0.0028 28.2  4.25 27.54  4.24 0.0527 0.209
Fasting blood glucose (mg/dl) 159.84  41.84 140.17  35.42 0.0948 144.28  49.1 159.12  45.39 0.2140 0.039
HbA1c (percent of total Hb) 7.63  0.92 7.21  0.94 0.0294 7.31  0.78 7.39  0.96 0.7600 0.115
HbA1c (mmol/mol) 59.92  10.10 55.83  11.89 0.0417 56.48  8.43 57.36  10.66 0.7612 0.107
Systolic blood pressure (mmHg) 141.28  16.52 131.88  15.17 0.0167 147.24  16.34 145.76  17.93 0.6921 0.194
Diastolic blood pressure (mmHg) 79.2  9.92 73.96  6.75 0.0298 78.76  13.05 81.4  13.85 0.4405 0.069
Total cholesterol (mg/dl) 176.2  29.99 171.0  33.71 0.6513 189.24  29.36 185.84  39.64 0.5983 0.991
HDL cholesterol (mg/dl) 54.08  14.7 50.0  13.39 0.0494 48.56  9.23 49.40  11.34 0.7130 0.117
LDL cholesterol (mg/dl) 97.0  27.16 95.79  30.45 0.9812 112.8  29.72 109.08  36.40 0.5417 0.674
Triglyceride (mg/dl) 125.72  87.43 122.33  68.61 0.9197 143.04  42.67 135.48  52.47 0.4468 0.794
Creatinine (mg/dl) 0.90  0.20 0.96  0.26 0.0149 0.86  0.20 0.97  0.27 0.0655 0.527
eGFR (ml/min) 98.67  25.48 93.11  24.77 0.0334 95.96  26.16 87.43  23.48 0.0877 0.725
ACR 2.88  4.14 1.42  2.23 0.0628 2.45  3.27 2.87  3.67 0.6561 0.114
Bold means statistically significant.
a Paired t-test for continuous variables.
Education improves blood pressure in type 2 diabetes 1977decreased body weight but from a direct effect of the ed-
ucation program. Although drug assumption was not
formally monitored, we suggest that Group Care, with its
emphasis on lifestyle attitudes and importance of phar-
macological medication, may have improved patient
adherence to anti-hypertensive prescriptions, which
remained unchanged throughout the trial. In contrast,
control patients followed by traditional individual ap-
pointments and education, maintained stable metabolic
control but worsened their blood pressure despite
increased prescription of anti-hypertensive drugs. Similar
findings were reported by Mühlhauser et al. [25] who
studied patients with hypertension e not diabetes and
hypertension e and over an 18 month follow up observed
a drop from 162/100 to 154/95 mmHg in the active group
vs 161/98 to 158/96 in the controls. The order of magni-







HADS_Depression 4.28  3.34 4.5  3.86 0.534
HADS_Anxiety 4.52  3.14 4.83  3.25 0.614
Locus Internal 30.16  5.01 31.88  4.17 0.080
Locus Chance 16.6  6.9 17.54  9.18 0.546
Locus Others 26.1  5.03 27.42  5.48 0.235
DQOL/Mod Total 68.2  11.73 66.17  10.49 0.294
DQOL/Mod Satisfaction 26.8  5.79 27.63  5.65 0.267
DQOL/Mod Impact 32.36  7.06 30.46  4.91 0.076
DQOL/Mod Complications 9.08  2.78 8.04  3.33 0.137
Self Esteem Scale 32.32  3.97 32.54  4.59 0.703
HADS Z Hospital Anxiety e Depression Scale.
Locus of Control tool.
DQOL/Mod Z Diabetes Quality of Life/Mod.
Bold means statistically significant.
a Paired t-test for continuous variables.among the active, and 147/79 to 146/81 among controls)
which, considering the different therapeutic targets and
drugs available in the early '90s, compares well. On the
other hand, ours were office measurements and no special
instructions were given to patients for home monitoring
blood pressure. Unfortunately, these effects on metabolic
and blood pressure control did not stop the decline in
renal function in either treatment group. The rise in serum
creatinine and corresponding drop in eGFR reached sta-
tistical significance in the Group Care group only, despite a
trend to decreased urinary albumin/creatinine ratio and
similar absolute values in both treatment groups. Lower
data dispersion and longer duration of disease in the
Group Care patients may have contributed to this result.
Other studies reported that adherence to medication
improves when people with chronic diseases are led to







8 4.24  3.02 3.44  2.95 0.2199 0.198
6 5.24  3.33 5.28  3.45 0.9260 0.706
5 30.64  3.97 30.96  4.35 0.6870 0.232
6 18.76  7.83 18.72  7.26 0.9772 0.618
2 24.2  4.91 26.44  5.45 0.0491 0.629
4 67.12  12.4 63.2  10.95 0.0600 0.431
9 30.92  7.98 28.28  6.86 0.0634 0.031
8 27.76  4.6 27.88  4.59 0.8968 0.143
7 8.44  2.95 7.08  2.94 0.0179 0.537
2 32.32  4.04 32.56  3.86 0.7860 0.918
Table 4 Differences between study groups: results from multivar-
iable models with difference between 4 years and baseline values of




Group Care L15.9 0.002
Known duration of diabetes 1.12 0.016
D BMI (4 years vs baseline)b 0.71 0.536
Oral antihypertensive agents at 4 years
No Ref e
Yes 6.24 0.237




Group Care 0.31 0.284
Known duration of diabetes 0.03 0.335
D BMI (4 years vs baseline)b 0.12 0.114
HbA1c at baseline 0.64 0.000
Bold means statistically significant.
a D SBP Z difference between 4 years and baseline values of
Systolic Blood Pressure.
b D BMI Z difference between 4 years and baseline values of BMI.
c D HbA1c Z difference between 4 years and baseline values of
HbA1c.
1978 M. Trento et al.stronger confidence in treatment [5]. A recent review
exploring health beliefs in people with hypertension
emphasized the importance of assessing individual beliefs,
in particular perceived barriers and self-efficacy, to incor-
porate them in the design of strategies to improve
adherence to medication [26].
Traditional diabetes education aims at imparting
disease-specific information about diet, exercise, medica-
tion and blood glucose monitoring skills in an approach in
which it is professionals who decide what to teach [7,11].
However, providing information may help improve
knowledge in patients but will not result in durable
adherence to a therapeutic regime, whereas a learning
process based upon the methodological principles of adult
education should address motivational aspects and
emotional regulation, acceptance of diabetes, coping stra-
tegies and narration of real life situations [27].
In Group Care, educational objectives are defined
together with the patients, who are helped to identify
and share their problems and successes with the other
participants and encouraged to report on their personal
experience. Peer education is used as a tool to compare
and learn strategies to manage life with diabetes. The
educational setting is characterized by continuity and
allows each person, over time, to talk about her/himself
by listening to what is said within the group, using the
positive dynamics of sharing and dialogue with other
people [26].
The only changes observed in the battery of psycho-
logical tests were a reduced fear of complications in the
Quality of Life scores of both patients on Group Care andcontrols, and a barely significant increase in the depen-
dence on Powerful Others in the Locus of Control of the
latter (Table 3). In previous post-hoc analyses, we had re-
ported lower fatalistic attitudes and stronger internality in
the Locus of Control of patients with T2D followed by
Group Care [14,15], and improved anxiety, depression and
self-esteem in a non-controlled follow up of patients with
type 1 diabetes, also managed by Group Care [16]. These
results, while confuting our previous data, underline the
necessity of subjecting partial observations to proper
randomized controlled trials.
This study has weaknesses. It was not, and could not be,
blinded because of the very nature of the intervention.
This is a common pitfall of all RCTs of non-pharmacological
interventions, which cannot conform to the rules of
double-blind placebo-controlled studies. Another short-
coming is that measurement of blood pressure was by
standard office procedures. Among the strengths are the
completeness of follow-up and data collection, the mini-
mal dropout rate and the fact that both intervention and
control groups were cared for by the same team of oper-
ators with a long experience in educational pathways for
adults with a chronic disease.
The results of this study confirm the importance of a
multidisciplinary approach to encourage the transmission
of useful messages that enable people with a chronic dis-
ease to make decisions in their own lives, understand the
value of self-care, improve health indicators and not be
overwhelmed by illness.
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